Literature DB >> 32860521

Optic neuritis as a presenting feature of Behçet's disease: case-based review.

Željka Kardum1,2, Jasminka Milas Ahić3,4, Ana Marija Lukinac3,4, Ružica Ivelj5, Višnja Prus3,4.   

Abstract

Behçet's disease (BD) is vasculitis affecting vessels of variable sizes characterized with recurrent oral and/or genital aphthous ulcers accompanied by cutaneous, ocular, articular, gastrointestinal, and/or central nervous system inflammatory lesions. The disease is characterized by recurrent attacks and remissions of different durations, which is one of the reasons why the diagnosis is, in most cases, made several years after the onset of first symptoms. We present a 24-year old male, with South Eastern European heritage, with relapsing bilateral optic neuritis as a first symptom of the disease, followed by aseptic meningitis 2 years, and vascular manifestation 3 years after onset, which finally led to the diagnosis of Behçet's disease. Vascular symptoms were thromboembolism of the right leg and aneurism of the right popliteal artery that due to the size required surgical treatment. The patient was treated with glucocorticoids, azathioprine and anti-tumor necrosis factor-alpha therapy, that proved to be the best treatment options for all manifestations of the disease. Based on our literature review, optic neuritis is a known and rare clinical feature of BD. To our knowledge, there are only several literature reports in which optic neuritis is the initial symptom of BD. Our case report and literature review emphasize the importance of recognizing optic neuritis without inflammatory eye disease as a possible presenting symptom of BD and accentuate detailed medical history review at each patient's visit.

Entities:  

Keywords:  Aneurysm; Behcet disease; Optic neuritis; Tumor necrosis factor inhibitors

Year:  2020        PMID: 32860521     DOI: 10.1007/s00296-020-04690-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  28 in total

Review 1.  Behçet's disease as an autoinflammatory disorder.

Authors:  Ahmet Gül
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-02

2.  Is Helicobacter pylori associated with Behçet's syndrome? A meta-analysis.

Authors:  Ye Yu; Xin Yao; Junyu Liang; Chao Lu; Tianlian Yan; Jin Lin
Journal:  Helicobacter       Date:  2019-10-16       Impact factor: 5.753

3.  2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Authors:  Gulen Hatemi; Robin Christensen; Dongsik Bang; Bahram Bodaghi; Aykut Ferhat Celik; Farida Fortune; Julien Gaudric; Ahmet Gul; Ina Kötter; Pietro Leccese; Alfred Mahr; Robert Moots; Yesim Ozguler; Jutta Richter; David Saadoun; Carlo Salvarani; Francesco Scuderi; Petros P Sfikakis; Aksel Siva; Miles Stanford; Ilknur Tugal-Tutkun; Richard West; Sebahattin Yurdakul; Ignazio Olivieri; Hasan Yazici
Journal:  Ann Rheum Dis       Date:  2018-04-06       Impact factor: 19.103

Review 4.  Behçet syndrome: a contemporary view.

Authors:  Hasan Yazici; Emire Seyahi; Gulen Hatemi; Yusuf Yazici
Journal:  Nat Rev Rheumatol       Date:  2018-01-03       Impact factor: 20.543

5.  Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease.

Authors:  Alexandre Le Joncour; Raphael Martos; Stephane Loyau; Nicolas Lelay; Antoine Dossier; Aurelie Cazes; Pierre Fouret; Fanny Domont; Thomas Papo; Martine Jandrot-Perrus; Marie-Christine Bouton; Patrice Cacoub; Nadine Ajzenberg; David Saadoun; Yacine Boulaftali
Journal:  Ann Rheum Dis       Date:  2019-05-30       Impact factor: 19.103

6.  Review of the chronology of clinical manifestations in 60 patients with Behçet's disease.

Authors:  Erkan Alpsoy; Levent Donmez; Ali Bacanli; Cemil Apaydin; Bulent Butun
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

Review 7.  'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.

Authors:  Dennis McGonagle; Sibel Zehra Aydin; Ahmet Gül; Alfred Mahr; Haner Direskeneli
Journal:  Nat Rev Rheumatol       Date:  2015-11-03       Impact factor: 20.543

8.  Behçet's syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments.

Authors:  Giacomo Emmi; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2019-07-17       Impact factor: 3.397

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

Review 10.  Immunopathogenesis of Behcet's Disease.

Authors:  Bainan Tong; Xiaoli Liu; Jun Xiao; Guanfang Su
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.